I would say the money should be spent in Canada. It should be spent on vaccine discovery development. One unmet need is a production facility. It should be spent there. Second, if not there, then it should be used to facilitate academic investigator-driven research on vaccine development in Canada.
On April 13th, 2010. See this statement in context.